This inventor holds 1 USPTO granted patent. Top assignee: Teijin Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovations of Takeyuki Kawaguhi
Introduction
Takeyuki Kawaguhi is a notable inventor based in Yamaguchi, Japan. He has made significant contributions to the field of medical materials, particularly in the development of materials that enhance antithrombotic activity. His work is crucial for advancements in medical technology, especially in applications involving blood contact.
Latest Patents
Kawaguhi holds a patent for a medical material containing fluorinated polysulfone that exhibits excellent antithrombotic activity. This innovative medical material is composed of a poly(alkyl aryl ether)sulfone copolymer and a thermoplastic polymer, such as cellulose triacetate. The design ensures that the concentration of the copolymer is at least 40% by weight near the surface that comes into contact with blood. This specific polysulfone, which bears fluorine atoms and polyalkyl ether units, is particularly suitable for use in hollow fiber membranes for artificial kidneys and similar applications. He has 1 patent to his name.
Career Highlights
Kawaguhi's career is marked by his dedication to research and innovation in medical materials. His work at Teijin Limited has positioned him as a key figure in the development of advanced medical technologies. His contributions have not only advanced the field but have also improved patient outcomes in medical treatments.
Collaborations
Throughout his career, Kawaguhi has collaborated with esteemed colleagues such as Hiroaki Kawahara and Satoru Ohmori. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
Takeyuki Kawaguhi's work in the field of medical materials showcases his commitment to innovation and excellence. His contributions are vital for the ongoing development of technologies that improve healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
